JNGLX
Price
$74.56
Change
+$0.48 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
LHCCX
Price
$19.77
Change
+$0.14 (+0.71%)
Updated
Oct 8 closing price
Net Assets
8.12M
Interact to see
Advertisement

JNGLX vs LHCCX

Header iconJNGLX vs LHCCX Comparison
Open Charts JNGLX vs LHCCXBanner chart's image
Janus Henderson Global Life Sciences D
Price$74.56
Change+$0.48 (+0.65%)
VolumeN/A
Net Assets4.49B
Lord Abbett Health Care C
Price$19.77
Change+$0.14 (+0.71%)
VolumeN/A
Net Assets8.12M
JNGLX vs LHCCX Comparison Chart in %
View a ticker or compare two or three
VS
JNGLX vs. LHCCX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.49B vs. LHCCX (8.12M). JNGLX pays higher dividends than LHCCX: JNGLX (0.33) vs LHCCX (0.00). JNGLX was incepted earlier than LHCCX: JNGLX (27 years) vs LHCCX (6 years). LHCCX (4.09) is less costly to investors than JNGLX (0.80). LHCCX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCCX has a lower initial minimum investment than JNGLX: LHCCX (1500) vs JNGLX (2500). LHCCX annual gain was more profitable for investors over the last year : 2.72 vs. JNGLX (-6.32). JNGLX return over 5 years is better than : 7.83 vs. LHCCX (-3.77).
JNGLXLHCCXJNGLX / LHCCX
Total Expense Ratio0.801.7845%
Annual Report Gross Expense Ratio0.804.0920%
Fund Existence27 years6 years-
Gain YTD9.1186.685136%
Front LoadN/AN/A-
Min. Initial Investment25001500167%
Min. Initial Investment IRAN/AN/A-
Net Assets4.49B8.12M55,234%
Annual Yield % from dividends0.330.00-
Returns for 1 year-6.322.72-232%
Returns for 3 years24.1824.4099%
Returns for 5 years7.83-3.77-207%
Returns for 10 years40.24N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHCCX4.20N/A
N/A
AB Discovery Growth C
TOLCX16.66N/A
N/A
DWS RREEF Global Infrastructure C
FIDZX38.34N/A
N/A
Fidelity Advisor Intl Cap App Z
SEKRX22.88N/A
N/A
DWS Emerging Markets Equity R6
PISJX16.05N/A
N/A
Columbia Pyrford International Stock R